1型糖尿病患者与非糖尿病人群进食障碍的发病率与治疗:一项全国性人群队列研究
该全国性人群队列纳入1998-2010年确诊的11,055例30岁以下1型糖尿病患者及按年龄、性别和医院区匹配的11,055名无糖尿病对照,平均随访13.1年。1型糖尿病组进食障碍发病175例,对照组75例,校正发病率比为2.35(95%CI 1.80, 3.09)。两组进食障碍患者精神药物处方相似,但1型糖尿病组接受门诊医院治疗较少(年均3.32次 vs 5.33次,校正差值1.24,95%CI 0.39, 2.08)。
要点
- 1型糖尿病患者进食障碍发病率高于无糖尿病对照,校正发病率比2.35(95%CI 1.80, 3.09)。
- 两组进食障碍患者精神药物处方相似。
- 1型糖尿病组进食障碍门诊医院治疗年均3.32次,少于对照组的5.33次。
核心结论
- 1型糖尿病患者较无糖尿病同龄人更易被诊断进食障碍,但尽管主要不良健康结局风险更高,其接受的门诊医院治疗更少。
- 作者认为这些发现强调需要为1型糖尿病患者提供针对性的进食障碍治疗。
研究设计与样本
- 全国性人群队列研究,纳入1998-2010年确诊的11,055例30岁以下1型糖尿病患者,及按年龄、性别和医院区匹配的11,055名无糖尿病对照。
- 采用泊松回归从医院记录确定进食障碍发病率,并通过精神药物新处方和进食障碍医院治疗评估治疗情况。
主要发现
- 平均随访13.1年,1型糖尿病组进食障碍新发病例175例,对照组75例,校正发病率比2.35(95%CI 1.80, 3.09)。
- 进食障碍患者中,伴与不伴1型糖尿病者的精神药物处方相似。
- 1型糖尿病组进食障碍门诊医院治疗年均3.32次,对照组5.33次,校正差值1.24(95%CI 0.39, 2.08)。
临床怎么用
- 作者认为这些发现强调需要为1型糖尿病患者提供针对性的进食障碍治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Eating disorders are over-represented in type 1 diabetes and are associated with an increased risk of complications, but it is unclear whether type 1 diabetes affects the treatment of eating disorders. We assessed incidence and treatment of eating disorders in a nationwide sample of individuals with type 1 diabetes and diabetes-free control individuals. METHODS: Our study comprised 11,055 individuals aged <30 who had been diagnosed with type 1 diabetes in 1998-2010, and 11,055 diabetes-free control individuals matched for age, sex and hospital district. We ascertained incidence of eating disorders from hospital records using Poisson regression. Eating disorder treatment was assessed by new prescriptions for psychotropic medications and hospital treatment for eating disorders. RESULTS: During a mean follow-up of 13.1 years, there were 175 incident cases of eating disorders among individuals with type 1 diabetes and 75 among the control individuals (adjusted incidence rate ratio 2.35; 95% CI 1.80, 3.09). The prescription of psychotropic medications was similar among eating disorder patients with and without type 1 diabetes. However, those with type 1 diabetes received outpatient hospital treatment for their eating disorder less often than those without diabetes (mean 3.32 vs 5.33 outpatient care visits per year [adjusted difference 1.24; 95% CI 0.39, 2.08]). CONCLUSIONS/INTERPRETATION: People with type 1 diabetes are more likely to be diagnosed with eating disorders than their diabetes-free peers. However, they receive less outpatient hospital treatment for their eating disorders despite their greater risk for major adverse health outcomes. These findings emphasise the need for targeted eating disorder treatment for people with type 1 diabetes.
引用
- Hirvelä L, Haukka J, Keski-Rahkonen A, et al. Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort. Diabetologia. 2025. PMID: 39755842. doi:10.1007/s00125-024-06346-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。